Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders.
Depression
Fibromyalgia
Sexual Desire
Journal
Sexual medicine
ISSN: 2050-1161
Titre abrégé: Sex Med
Pays: England
ID NLM: 101631053
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
04
06
2021
revised:
06
10
2021
accepted:
09
10
2021
pubmed:
29
11
2021
medline:
29
11
2021
entrez:
28
11
2021
Statut:
ppublish
Résumé
Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia. To investigate on the one hand the global sexual desire, the dyadic sexual and solitary sexual desire, and on the other hand the association with depressive symptoms, fibromyalgia symptoms and medication use among women with fibromyalgia in Flanders, Belgium. An online survey was spread through the Flemish league for Fibromyalgia Patients to be completed by women with fibromyalgia. The sexual desire inventory-2 (SDI-2) was used to measure sexual desire (global, dyadic, solitary), the VASFIQ for fibromyalgia symptoms, and the PHQ-2 for depressive symptoms, while also including questions on demographic factors (time since FM, age) and medication usage (antidepressants, pain medication, sleeping medication). Global sexual desire, dyadic sexual desire and solitary sexual desire were studied in relation to depressive symptoms, medication use and fibromyalgia symptoms. One hundred and three women with FM answered the survey. Depressive symptoms were significantly associated with a lower global, dyadic and solitary sexual desire, as was the use of antidepressant medication. The association between solitary sexual desire and depressive symptoms disappeared when controlled for antidepressant medication. Age, fibromyalgia symptoms nor time since diagnosis were significantly associated with any form of sexual desire. Depressive symptoms and antidepressant medication, and not fibromyalgia symptoms, were associated with decreased sexual desire of women with FM. As antidepressant medication and depressive symptoms are associated with a decreased sexual desire, more attention should be paid towards the mental health issues associated with fibromyalgia, as well as the prescription of antidepressant medication. This study is the first to investigate sexual desire among women with fibromyalgia in Flanders, and one of the few internationally to have done so. It is limited by its cross-sectional design, and for not providing information on men with FM. Van Overmeire R, Vesentini L, Vanclooster S, et al. Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders. Sex Med 2022;10:100457.
Sections du résumé
BACKGROUND
BACKGROUND
Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia.
AIM
OBJECTIVE
To investigate on the one hand the global sexual desire, the dyadic sexual and solitary sexual desire, and on the other hand the association with depressive symptoms, fibromyalgia symptoms and medication use among women with fibromyalgia in Flanders, Belgium.
METHODS
METHODS
An online survey was spread through the Flemish league for Fibromyalgia Patients to be completed by women with fibromyalgia. The sexual desire inventory-2 (SDI-2) was used to measure sexual desire (global, dyadic, solitary), the VASFIQ for fibromyalgia symptoms, and the PHQ-2 for depressive symptoms, while also including questions on demographic factors (time since FM, age) and medication usage (antidepressants, pain medication, sleeping medication).
MAIN OUTCOME MEASURE
METHODS
Global sexual desire, dyadic sexual desire and solitary sexual desire were studied in relation to depressive symptoms, medication use and fibromyalgia symptoms.
RESULTS
RESULTS
One hundred and three women with FM answered the survey. Depressive symptoms were significantly associated with a lower global, dyadic and solitary sexual desire, as was the use of antidepressant medication. The association between solitary sexual desire and depressive symptoms disappeared when controlled for antidepressant medication. Age, fibromyalgia symptoms nor time since diagnosis were significantly associated with any form of sexual desire.
CONCLUSION
CONCLUSIONS
Depressive symptoms and antidepressant medication, and not fibromyalgia symptoms, were associated with decreased sexual desire of women with FM. As antidepressant medication and depressive symptoms are associated with a decreased sexual desire, more attention should be paid towards the mental health issues associated with fibromyalgia, as well as the prescription of antidepressant medication. This study is the first to investigate sexual desire among women with fibromyalgia in Flanders, and one of the few internationally to have done so. It is limited by its cross-sectional design, and for not providing information on men with FM. Van Overmeire R, Vesentini L, Vanclooster S, et al. Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders. Sex Med 2022;10:100457.
Identifiants
pubmed: 34839232
pii: S2050-1161(21)00137-9
doi: 10.1016/j.esxm.2021.100457
pmc: PMC8847810
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100457Informations de copyright
Copyright © 2021 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
Références
J Back Musculoskelet Rehabil. 2020;33(3):355-361
pubmed: 29562491
Reumatismo. 2012 Sep 28;64(4):261-7
pubmed: 23024970
J Adv Nurs. 2017 Jul;73(7):1646-1656
pubmed: 28122137
J Affect Disord. 2019 Feb 15;245:1098-1105
pubmed: 30699852
Rheumatol Int. 2021 Aug;41(8):1471-1477
pubmed: 33725132
Med Clin (Barc). 2017 Nov 22;149(10):441-448
pubmed: 28734619
Neuropsychiatr Dis Treat. 2016 Feb 16;12:349-55
pubmed: 26937190
Pain Physician. 2019 Sep;22(5):E511-E516
pubmed: 31561664
Ther Adv Musculoskelet Dis. 2011 Oct;3(5):215-26
pubmed: 22870480
Ann Intern Med. 2020 Mar 3;172(5):ITC33-ITC48
pubmed: 32120395
J Womens Health (Larchmt). 2006 Nov;15(9):1035-45
pubmed: 17125422
J Sex Med. 2019 Oct;16(10):1518-1528
pubmed: 31501059
J Sex Marital Ther. 2020;46(4):361-376
pubmed: 32000629
Clin Rheumatol. 2009 Apr;28(4):365-9
pubmed: 19165555
Aust J Prim Health. 2016;22(3):262-266
pubmed: 26306421
Int J Impot Res. 2019 Jul;31(4):288-297
pubmed: 30467351
Womens Health (Lond). 2018 Jan-Dec;14:1745506518762664
pubmed: 29649948